Co-Diagnostics Expands MENA Footprint with WHX Labs Dubai Showcase

Event summary

  • Co-Diagnostics to exhibit at WHX Labs Dubai Feb 10–13, 2026, showcasing its PCR platform.
  • Joint venture CoMira Diagnostics targets MENA region manufacturing and distribution.
  • Co-Dx PCR platform still under FDA review, not yet commercially available.
  • Event follows recent Saudi Arabia joint venture with Arabian Eagle Manufacturing.

The big picture

Co-Diagnostics' participation at WHX Labs Dubai underscores its strategic push into the MENA region, leveraging local partnerships to bypass import barriers. The move aligns with broader trends in diagnostics where regional manufacturing hubs are becoming critical for market access. Success hinges on navigating regulatory hurdles and executing on the joint venture's operational promises.

What we're watching

Regulatory Approval
The pace at which Co-Dx PCR platform secures FDA approval will determine commercialization timelines.
Market Penetration
Whether CoMira Diagnostics can effectively establish local manufacturing and distribution in the MENA region.
Strategic Partnerships
How World Trade Center Utah collaboration impacts Co-Diagnostics' international expansion efforts.

Related topics

Joint Venture